Cardiovascular side effects of small molecule therapies for cancer.

@article{Pun2016CardiovascularSE,
  title={Cardiovascular side effects of small molecule therapies for cancer.},
  author={S. Pun and T. Neilan},
  journal={European heart journal},
  year={2016},
  volume={37 36},
  pages={
          2742-2745
        }
}
Targeted therapies such as monoclonal antibodies and small molecule inhibitors of protein kinases, have improved the prognosis for patients with a wide range of cancers. Several of these classes of therapies are associated with cardiovascular and metabolic sequelae. These include heart failure or an asymptomatic decline in ejection fraction, peripheral and cardiac ischemic events, pulmonary hypertension, arrhythmias and QT-prolongation. This review will focus on the following targeted… Expand
9 Citations
Cardiotoxicity of Anticancer Therapeutics
  • 37
  • Highly Influenced
Novel Screening Method Identifies PI3Kα, mTOR, and IGF1R as Key Kinases Regulating Cardiomyocyte Survival
  • PDF
Cardiotoxicity: a challenge for modern oncology
  • 1
  • PDF
Left ventricular dysfunction associated with axitinib and nivolumab experience in an advanced renal cell carcinoma
  • 1
Cardio-oncology: a new specialty moves to centre stage.
  • 1
  • PDF